Literature DB >> 12481988

A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family.

Donna-Maria Georgiou1, Janez Zidar, Marko Korosec, Lefkos T Middleton, Theodoros Kyriakides, Kyproula Christodoulou.   

Abstract

Charcot-Marie-Tooth (CMT) disease is the most-common form of inherited motor and sensory neuropathy. The autosomal dominant axonal form of the disease (CMT2) is currently subdivided into seven types based on genetic localization. These are CMT2A (1p35-p36), CMT2B (3q13-q22), CMT2C (unknown), CMT2D (7p14), CMT2E (8p21), HMNSP (3q13.1), and CMT2F (7q11-q21). Two loci have thus far been identified for autosomal recessive CMT2; ARCMT2A (1q21.1-q21.3) and ARCMT2B (19q13.3). Mutations in four genes (connexin 32, myelin protein zero, neurofilament-light, and kinesin) have been associated with the CMT2 phenotype. We identified a novel neurofilament-light missense mutation (C64T) that causes the disease in a large Slovenian CMT2 family. This novel mutation shows complete co-segregation with the dominantly inherited CMT2 phenotype in our family.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12481988     DOI: 10.1007/s10048-002-0138-4

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  28 in total

1.  Exacerbation of Charcot-Marie-Tooth type 2E neuropathy following traumatic nerve injury.

Authors:  Eric Villalón; Jeffrey M Dale; Maria Jones; Hailian Shen; Michael L Garcia
Journal:  Brain Res       Date:  2015-09-28       Impact factor: 3.252

2.  NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.

Authors:  José Berciano; Antonio García; Kristien Peeters; Elena Gallardo; Els De Vriendt; Ana L Pelayo-Negro; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

3.  Expressing hNF-LE397K results in abnormal gaiting in a transgenic model of CMT2E.

Authors:  J M Dale; E Villalon; S G Shannon; D M Barry; R M Markey; V B Garcia; M L Garcia
Journal:  Genes Brain Behav       Date:  2012-02-23       Impact factor: 3.449

4.  Muscle pathology without severe nerve pathology in a new mouse model of Charcot-Marie-Tooth disease type 2E.

Authors:  Hailian Shen; Devin M Barry; Jeffrey M Dale; Virginia B Garcia; Nigel A Calcutt; Michael L Garcia
Journal:  Hum Mol Genet       Date:  2011-04-14       Impact factor: 6.150

5.  Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation.

Authors:  Miora Feinstein; Barak Markus; Iris Noyman; Hannah Shalev; Hagit Flusser; Ilan Shelef; Keren Liani-Leibson; Zamir Shorer; Idan Cohen; Shareef Khateeb; Sara Sivan; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2010-11-18       Impact factor: 11.025

Review 6.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

7.  Neurofilaments bind tubulin and modulate its polymerization.

Authors:  Arnaud Bocquet; Raphael Berges; Ronald Frank; Patrick Robert; Alan C Peterson; Joël Eyer
Journal:  J Neurosci       Date:  2009-09-02       Impact factor: 6.167

Review 8.  A review of genetic counseling for Charcot Marie Tooth disease (CMT).

Authors:  Carly E Siskind; Seema Panchal; Corrine O Smith; Shawna M E Feely; Joline C Dalton; Alice B Schindler; Karen M Krajewski
Journal:  J Genet Couns       Date:  2013-04-21       Impact factor: 2.537

Review 9.  Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.

Authors:  Henry Houlden; Mary M Reilly
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

10.  Defective axonal transport of Rab7 GTPase results in dysregulated trophic signaling.

Authors:  Kai Zhang; Rotem Fishel Ben Kenan; Yasuko Osakada; Wei Xu; Rachel S Sinit; Liang Chen; Xiaobei Zhao; Jia-Yun Chen; Bianxiao Cui; Chengbiao Wu
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.